For The Record

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

For The Record

posted on Sep 28, 2022 06:58AM

I bought "ZHCLF" (Zenith Capital Corp) stock on the OTC Market post April 8, 2013, Resverlogix Corp's spin-out of its subsidiary RVX therapeutics.

I have just received my Management Information Circular in connection with Zenith's Annual Meeting of Shareholders to be held on October 27, 2022. This confirms that the "ZHCLF" stock symbol trading on the OTC markets is in fact Zenith Capital Corp, as we know it.